Kinetic Targeting of pegylated liposomal Doxorubicin: a new Approach to Reduce Toxicity during Chemotherapy (CARL-trial)

Table 4 Questionnaire Plasmapheresis

How did you feel ...	very good	good	moderately	poor
- prior to plasmapheresis	1	36	11	2
- during plasmapheresis	1	40	7	2
- immediately after plasmapheresis	1	41	6	2
in between plasmapheresis and next cycle (not assessed after last cycle)	0	25	9	2
	no	little	moderate	high
Classify your effort for plasmapheresis treatment today	8	25	10	7

To asses any direct impact of plasmapheresis on Quality of life, a custom-made questionnaire was given to the patients after each cycle. 50 cycles in total were evaluated. No significant change between different cycles became apparent.

ISSN: 1471-2407